# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY

A. 510(k) Number: K092585   
B. Purpose for Submission: Clearance of new device for the Calibration control test system   
C. Measurand: Rubella-specific IgG in human serum and plasma   
D. Type of Test: Calibration verification material for Rubella IgG   
E. Applicant: Roche Diagnostics   
F. Proprietary and Established Names: Elecsys Rubella IgG CalCheck 5; Rubella IgG CalCheck 5

# G. Regulatory Information:

1. Regulation section: 21CFR §862.1660, Quality control material (assayed and unassayed) 21CFR $\ S 8 6 6 . 3 5 1 0$ , Rubella virus serological reagents

2. Classification: Class II (Rubella IgG)

3. Product code: JJX, Single (Specified) Analyte Controls (Assayed and Unassayed) LFX, Enzyme Linked Immunoabsorbent Assay, Rubella

# H. Intended Use:

1. Intended use(s): The Elecsys Rubella IgG CalCheck 5 is an assayed control for use in calibration verification and for use in the verification of the assay range established by the Elecsys Rubella IgG reagent on the Elecsys 2010, MODULAR ANALYTICS E170 and cobas e immunoassay analyzers.

2. Indication(s) for use: Same as intended use

3. Special conditions for use statement(s): For prescription use only. To be used with the Elecsys Rubella IgG assay

4. Special instrument requirements: Elecsys 2010, MODULAR ANALYTICS E170, or cobas e analyzers

# I. Device Description:

The Elecsys Rubella IgG CalCheck 5 is a lyophilized product consisting of human anti-Rubella IgG antibodies in human serum matrix. During manufacture, the analyte is spiked into the matrix at the desired concentration levels

# J. Substantial Equivalence Information:

1. Predicate device name(s): Elecsys Rubella IgG CalCheck

2. Predicate K number(s): K090311

3. Comparison with predicate:

<table><tr><td colspan="3" rowspan="1">Comparison</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">PredicateElecsys Rubella IgG CalCheck(K090311)</td><td colspan="1" rowspan="1">DeviceElecsys Rubella IgGCalCheck 5</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">For use in the verification of thecalibration established by the ElecsysRubella IgG reagent on the Elecsys2010, the MODULAR ANALYTICSE170, and cobas e immunoassayanalyzers.</td><td colspan="1" rowspan="1">For use in the verification ofthe reportable rangeestablished by the ElecsysRubella IgG reagent on theElecsys and cobas eimmunoassay analyzers</td></tr><tr><td colspan="1" rowspan="1">Levels</td><td colspan="1" rowspan="1">Three</td><td colspan="1" rowspan="1">Five</td></tr><tr><td colspan="1" rowspan="1">Format</td><td colspan="1" rowspan="1">Lyophilized</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Handling</td><td colspan="1" rowspan="1">Reconstitute with exactly 1.0 mLdistilled or deionized water and allowstanding closed for 15 minutes, thenmix gently.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Stability</td><td colspan="1" rowspan="1">Unopened:Store at 2-8°C until expiration dateReconstituted:20 - 25°C: 4 hrs</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Matrix</td><td colspan="1" rowspan="1">Human Serum</td><td colspan="1" rowspan="1">Same</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

Guidance for Industry and FDA Staff - Assayed and Unassayed Quality Control Material (http://www.fda.gov/cdrh/oivd/guidance/2231.html)

# L. Test Principle:

“Calibration verification is the assaying of calibration materials in the same manner as patient samples to confirm that the calibration of the instrument or test system has remained stable throughout the laboratory’s reportable range for patient test results.” (42 Code of U.S. Federal Regulations. Part 493.1217. Standard; Calibration and calibration verification procedures.) (sic.)

Calibration verification is not a requirement of the Elecsys and cobas e immunoassay systems based on the manufacturer’s recommendations. However, CalCheck solutions can be used in instances where such a test procedure is required by certification agencies, or where the user wishes to document calibration verification.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility: Not applicable

b. Linearity/assay range:

Verification of Assay Range: To demonstrate that after dilution of Rubella IgG CalCheck 1 and 5 values are within the assay’s measuring range of 0.21 - $5 0 0 \ \mathrm { I U / m L }$ , the following dilution study was performed:

CalCheck 1 & CalCheck 2, CalCheck 4 & CalCheck 5, and CalCheck 5 & CalCheck 3 were mixed in a 1:1 ratio and measured in two-fold determination. Then the average was calculated.

Result: Both CalCheck 1 & CalCheck 2 and CalCheck 3 & CalCheck 5 dilution values are within the assay’s measuring range after dilution. CalCheck 4 & CalCheck 5 dilution values were outside of the assay’s measuring range, however, CalCheck 3 & CalCheck 5 dilution was within the assay’s measuring range.

<table><tr><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>Value after1:1 Dilution[IU/mL]</td><td rowspan=1 colspan=1>Average1:1 Dilution[IU/mL]</td></tr><tr><td rowspan=1 colspan=1>CalCheck 1 + CalCheck 2CalCheck 1 + CalCheck 2</td><td rowspan=1 colspan=1>4.804.84</td><td rowspan=1 colspan=1>4.82</td></tr><tr><td rowspan=2 colspan=1>CalCheck 4 + CalCheck 5CalCheck 4 + CalCheck 5CalCheck 3 + CalCheck 5CalCheck 3 + CalCheck 5</td><td rowspan=1 colspan=1>511.0519.6</td><td rowspan=1 colspan=1>515.3</td></tr><tr><td rowspan=1 colspan=1>435.3437.2</td><td rowspan=1 colspan=1>436.3</td></tr></table>

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

Traceability:

Elecsys Rubella IgG CalCheck 5 is standardized against the NIBSC 1st International Standard for Anti-Rubella Immunoglobulin, Human. The NIBSC standard is reconstituted and a serial dilution set is created from it. A master curve is derived using the NIBSC dilution set. The master calibrators are assigned values using the master curve. From the master calibrators a master curve is derived. In turn the CalChecks are assigned values using the master curve based on the master calibrators. Values are assigned using a minimum of,

4 Elecsys2010/cobas e 411 analyzers,   
4 MODULAR ANALYTICS E170/ cobas e 601 analyzers.

Six independent series of analyses are performed on each instrument. Each sample is tested in duplicate. The target value is then calculated as the median of the determined values. Approximate target values are given in the table below. Lot-specific target values may differ slightly after value assignment.

<table><tr><td rowspan=1 colspan=1>Rubella IgG CalCheck 5Level</td><td rowspan=1 colspan=1>Rubella IgG AssignedValues and Ranges</td></tr><tr><td rowspan=1 colspan=1>Level 1 (Lot 179241)</td><td rowspan=1 colspan=1>&lt;2</td></tr><tr><td rowspan=1 colspan=1>Level 2 (Lot 151729)</td><td rowspan=1 colspan=1>9.52 IU/mL (5.81-13.2)</td></tr><tr><td rowspan=1 colspan=1>Level 3 (Lot 179243)</td><td rowspan=1 colspan=1>270 IU/mL (165-375)</td></tr><tr><td rowspan=1 colspan=1>Level 4 (Lot 179244)</td><td rowspan=1 colspan=1>421 IU/mL (257-585)</td></tr><tr><td rowspan=1 colspan=1>Level 5(Lot 179245)</td><td rowspan=1 colspan=1>514 IU/mL (314-714)</td></tr></table>

Stability:

Two studies were performed in order to verify the stability claims for the Elecsys Rubella IgG CalCheck. The data was generated using Rubella IgG master calibrators, which have the same composition and target values as Rubella IgG CalCheck 5. The acceptance criterion was recovery of $90 \mathrm { - } 1 1 0 \%$ of the reference value, which was accomplished. The reconstituted Elecsys Rubella IgG CalCheck 5 is stable up to 4 hours at $2 0 – 2 5 ^ { \circ } \mathrm { C }$ .

# Expected Range:

The approximate target ranges were included in the Package Insert as given below in the table. It was recommended to refer to the value sheet on www. MyLabOnline.com for lot-specific range.

<table><tr><td rowspan=1 colspan=1>Level</td><td rowspan=1 colspan=1>ApproximateTarget Range</td><td rowspan=1 colspan=1>Unit</td></tr><tr><td rowspan=1 colspan=1>Check 1</td><td rowspan=1 colspan=1>&lt; 2.00</td><td rowspan=1 colspan=1>IU/mL</td></tr><tr><td rowspan=1 colspan=1>Check 2</td><td rowspan=1 colspan=1>6.10 - 13.9</td><td rowspan=1 colspan=1>IU/mL</td></tr><tr><td rowspan=1 colspan=1>Check 3</td><td rowspan=1 colspan=1>153 - 348</td><td rowspan=1 colspan=1>IU/mL</td></tr><tr><td rowspan=1 colspan=1>Check 4</td><td rowspan=1 colspan=1>244 - &gt;500</td><td rowspan=1 colspan=1>IU/mL</td></tr><tr><td rowspan=1 colspan=1>Check 5</td><td rowspan=1 colspan=1>300 - &gt; 500</td><td rowspan=1 colspan=1>IU/mL</td></tr></table>

d. Detection limit: Not applicable e. Analytical specificity: Not applicable f. Assay cut-off: Not applicable

2. Comparison studies:

a. Method comparison with predicate device: Not applicable b. Matrix comparison: Not applicable

3. Clinical studies: a. Clinical Sensitivity: Not applicable b. Clinical specificity: Not applicable c. Other clinical supportive data (when a. and b. are not applicable): Not applicable

4. Clinical cut-off: Not applicable

5. Expected values/Reference range:

Representative values assigned to five lots: 179241, 151729, 179243, 179244, and 179245 of the product.

<table><tr><td rowspan=1 colspan=1>Level</td><td rowspan=1 colspan=1>Value</td><td rowspan=1 colspan=1>Range</td><td rowspan=1 colspan=1>Unit</td></tr><tr><td rowspan=1 colspan=1>Level 1</td><td rowspan=1 colspan=1>&lt; 2.00</td><td rowspan=1 colspan=1>&lt; 2.00</td><td rowspan=1 colspan=1>IU/mL</td></tr><tr><td rowspan=1 colspan=1>Level 2</td><td rowspan=1 colspan=1>9.52</td><td rowspan=1 colspan=1>5.81 -13.2</td><td rowspan=1 colspan=1>IU/mL</td></tr><tr><td rowspan=1 colspan=1>Level 3</td><td rowspan=1 colspan=1>270</td><td rowspan=1 colspan=1>165 -375</td><td rowspan=1 colspan=1>IU/mL</td></tr><tr><td rowspan=1 colspan=1>Level 4</td><td rowspan=1 colspan=1>421</td><td rowspan=1 colspan=1>257 - &gt; 500</td><td rowspan=1 colspan=1>IU/mL</td></tr><tr><td rowspan=1 colspan=1>Level 5</td><td rowspan=1 colspan=1>&gt; 500</td><td rowspan=1 colspan=1>314 - &gt; 500</td><td rowspan=1 colspan=1>IU/mL</td></tr></table>

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.